Literature DB >> 380444

Tissue adhesion with highly concentrated human fibrinogen in otolaryngology.

O Staindl.   

Abstract

This paper summarizes a tissue adhesive system consisting of highly concentrated human fibrinogen and thrombin. The addition of blood-clotting factor XIII stabilizes the adhesive system against fibrinolysis. Although the adhesion system cannot and should not replace surgical suture, it provides valuable assistance in tissue synthesis and in local hemostasis, particularly in cases where conventional suture methods are especially difficult to apply. In addition to good adhesion, an elastic consistency, and good tissue compatibility, the adhesive is completely absorbed and, therefore, preferable to conventional tissue adhesives based on cyanoacrylate. The system has been used successfully in split thickness skin graft application, myringoplasty, repair of dural defects, hemostasis after tonsillectomy, and achieving an airtight seal in tracheoplasty.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 380444     DOI: 10.1177/000348947908800320

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  Skull base cerebrospinal fluid leakage control with a fibrin-based composite tissue adhesive.

Authors:  J P Rock; D H Sierra; F Castro-Moure; F Jiang
Journal:  Skull Base Surg       Date:  1996

2.  Endaural extracranial repair for cerebrospinal otorrhoea with human fibrin glue: technical note.

Authors:  L Ferrante; E Palatinsky; M Acqui; L Mastronardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

3.  The healing of wounds and scar formation under the influence of a tissue adhesion system with fibrinogen, thrombin, and coagulation factor XIII.

Authors:  O Staindl
Journal:  Arch Otorhinolaryngol       Date:  1979

Review 4.  Design strategies and applications of tissue bioadhesives.

Authors:  Mohammadreza Mehdizadeh; Jian Yang
Journal:  Macromol Biosci       Date:  2012-12-06       Impact factor: 4.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.